Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge

Emily Boja, Živana Težak, Bing Zhang, Pei Wang, Elaine Johanson, Denise Hinton, Henry Rodriguez

Research output: Contribution to journalComment/debate

16 Scopus citations

Abstract

To address a critical roadblock that can occur in translational and clinical research, the National Cancer Institute and the Food and Drug Administration, in coordination with the DREAM Challenges, are launching the first computational challenge using multi-omics datasets to detect and correct specimen mislabeling.

Original languageEnglish
Pages (from-to)1301-1302
Number of pages2
JournalNature Medicine
Volume24
Issue number9
DOIs
StatePublished - 1 Sep 2018

Fingerprint

Dive into the research topics of 'Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge'. Together they form a unique fingerprint.

Cite this